Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas W Morrell

Showing results (151-160 of 278) with videos related to

Pageof 28
Sort By:
New Biotechnology|February 15, 2021
Clinically compatible advances in blood-derived endothelial progenitor cell isolation and reprogramming for translational applicationsSarah Eminli, Baraa Kwieder, Kevin Yi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 5, 2022
Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertensionKellen Hirsch, Stephanie Nolley, David D Ralph, et al.
American Journal of Respiratory Cell and Molecular Biology|February 19, 2013
Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertensionTakeshi Ogo, H M Chowdhury, Jun Yang, et al.
Pulmonary Circulation|April 25, 2012
(18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle studyGuy Hagan, Mark Southwood, Carmen Treacy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2016
Bone Morphogenetic Protein 9 Enhances Lipopolysaccharide-Induced Leukocyte Recruitment to the Vascular EndotheliumSarah L Appleby, Claudia-Gabriela Mitrofan, Alexi Crosby, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2010
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapyHossein A Ghofrani, Nicholas W Morrell, Marius M Hoeper, et al.
Nature Communications|April 3, 2020
Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound formsRichard M Salmon, Jingxu Guo, Jennifer H Wood, et al.
Scientific Reports|April 24, 2023
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cellsClara Andersson-Rusch, Bin Liu, Ingrid Quist-Løkken, et al.
American Journal of Respiratory and Critical Care Medicine|June 16, 2015
Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertensionElaine Soon, Alexi Crosby, Mark Southwood, et al.
Pulmonary Circulation|August 23, 2017
Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodelingJosephine Pickworth, Alexander Rothman, James Iremonger, et al.
Pageof 28

Showing results (151-160 of 278) with videos related to

Sort By:
Pageof 28
New Biotechnology|February 15, 2021
Clinically compatible advances in blood-derived endothelial progenitor cell isolation and reprogramming for translational applicationsSarah Eminli, Baraa Kwieder, Kevin Yi, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 5, 2022
Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertensionKellen Hirsch, Stephanie Nolley, David D Ralph, et al.
American Journal of Respiratory Cell and Molecular Biology|February 19, 2013
Inhibition of overactive transforming growth factor-β signaling by prostacyclin analogs in pulmonary arterial hypertensionTakeshi Ogo, H M Chowdhury, Jun Yang, et al.
Pulmonary Circulation|April 25, 2012
(18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle studyGuy Hagan, Mark Southwood, Carmen Treacy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2016
Bone Morphogenetic Protein 9 Enhances Lipopolysaccharide-Induced Leukocyte Recruitment to the Vascular EndotheliumSarah L Appleby, Claudia-Gabriela Mitrofan, Alexi Crosby, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2010
Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapyHossein A Ghofrani, Nicholas W Morrell, Marius M Hoeper, et al.
Nature Communications|April 3, 2020
Molecular basis of ALK1-mediated signalling by BMP9/BMP10 and their prodomain-bound formsRichard M Salmon, Jingxu Guo, Jennifer H Wood, et al.
Scientific Reports|April 24, 2023
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cellsClara Andersson-Rusch, Bin Liu, Ingrid Quist-Løkken, et al.
American Journal of Respiratory and Critical Care Medicine|June 16, 2015
Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertensionElaine Soon, Alexi Crosby, Mark Southwood, et al.
Pulmonary Circulation|August 23, 2017
Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodelingJosephine Pickworth, Alexander Rothman, James Iremonger, et al.
Pageof 28